SEC Form 6-K filed by Medigus Ltd.

$MDGS
Medical/Dental Instruments
Health Care
Get the next $MDGS alert in real time by email
6-K 1 ea0203894-6k_xylotech.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of April 2024

 

Commission File Number: 001-37381

 

XYLO TECHNOLOGIES LTD.

(Translation of registrant’s name into English) 

 

10 HaNechoshet Street, Tel-Aviv, 6971072, Israel

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F

 

 

 

 

 

 

On April 1, 2024, a lawsuit seeking declaratory judgement was filed in the District Court of Tel Aviv-Jaffa in Israel by minority shareholders of Eventer Technologies Ltd. (“Eventer”), a subsidiary of Medigus Ltd. (now known as Xylo Technologies Ltd.) (the “Company”, and together, the “Defendants”). The minority shareholders of Eventer (the “Plaintiffs”), hold in aggregate 31.86% of the Outstanding Ordinary Shares of Eventer. The Plaintiffs allege, among others, that Defendants violated the agreement whereby the Company acquired control of Eventer (the “Purchase Agreement”), which established a “separation” mechanism, within which certain Plaintiffs were granted an option to convert their shares in Eventer into shares of the Company. The claim alleges that the Company has violated the terms of the Purchase Agreement by refusing to negotiate Eventer’s valuation to enable certain of the Plaintiffs to exercise their option to convert their shares of Eventer into shares of the Company. The Plaintiffs seek an aggregate of NIS 1,228,500 from Eventer (approximately $335,380) and seek to convert the Eventer shares into Company shares for an aggregate value of NIS 8,602,200 (approximately $2,348,200) following which all the Plaintiffs shares in Eventer would be transferred to the Company. The Company has not yet submitted its response to the District Court of Tel Aviv – Jaffa. The Company’s position is that the lawsuit has no merit, and it intends to defend its position vigorously. As of date hereof, the Company is unable to estimate a loss or range of loss of this lawsuit.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  XYLO TECHNOLOGIES LTD.
   
  By: /s/ Tali Dinar
  Name:  Tali Dinar
  Title: Chief Financial Officer

 

Date: April 15, 2024

 

 

2

 

 

Get the next $MDGS alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MDGS

DatePrice TargetRatingAnalyst
More analyst ratings

$MDGS
Press Releases

Fastest customizable press release news feed in the world

See more
  • Xylo Technologies: Revoltz Receives Israeli Standards Institute Approval for PORTO EV Micro Vehicle

    TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Revoltz Ltd ("Revoltz"), which is 19.9% held by Charging Robotics, Inc. (OTC:CHEV) ("Charging Robotics"), a Delaware corporation quoted on the OTC Market (63.7% owned by Xylo), has received approval from the Israeli Standards Institute to sell and market its PORTO EV micro vehicle in Israel. The Israeli Standards Institute approval (Standard 6230 Type Approval) is a critical milestone, as it enables PORTO EV riders as young as 16 to operate the vehicle without requiring a driver's li

    $MDGS
    $XYLO
    Medical/Dental Instruments
    Health Care
  • Xylo Technologies: ParaZero Received Order from a Leading Tier-One Defense Company for 50 Drone Safety Systems

    TEL AVIV, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that ParaZero Technologies Ltd. (NASDAQ:PRZO) ( "ParaZero"), an aerospace company focused on drone safety systems for defense and commercial drones and urban air mobility aircraft (18.68% owned by Xylo), initiated a partnership with a leading Tier 1 defense OEM company to adapt and integrate its advanced drone safety system for operational military and medical mission use. ParaZero received an initial order as part of a wider collaboration that aims to enhance the efficiency and safety of

    $MDGS
    $PRZO
    $XYLO
    Medical/Dental Instruments
    Health Care
    Military/Government/Technical
    Industrials
  • Xylo Technologies: Revoltz to Launch an Innovative Three-Wheel Electric Cargo Bike for European and UK Markets

    TEL AVIV, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Revoltz Ltd ("Revoltz"), which is 19.9% held by Charging Robotics, Inc. (OTC:CHEV) ("Charging Robotics"), a Delaware corporation quoted on the OTC Market (67% owned by Xylo), has developed a new, three-wheel, electric cargo bike tailored for the European and UK markets. Building on the success of Revoltz's PORTO micro-EV, this new bike is designed to offer enhanced stability, increased payload capacity, and high-caliber safety features, making it fit for urban transportation and comme

    $MDGS
    $XYLO
    Medical/Dental Instruments
    Health Care

$MDGS
SEC Filings

See more

$MDGS
Leadership Updates

Live Leadership Updates

See more
  • Medigus: ScoutCam Announces Appointment of Yehu Ofer as Chief Executive Officer

    Tel Aviv, Israel, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) ("Medigus"), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle ("EV") and charging solutions, announced today that ScoutCam Inc. (OTCQB:SCTC) ("ScoutCam", owned 27.02% by Medigus), a leading provider of visualization and AI based solutions to the Condition Based Monitoring (CBM) and the Predictive Maintenance (PdM) markets, announced the appointment of Yehu Ofer as chief executive officer, effective immediately. Mr. Ofer, a former Israeli Air Force (IAF) pilot and commander, as well as a leading professional in the aviation and aerospace industries,

    $MDGS
    Medical/Dental Instruments
    Health Care
  • Medigus: ScoutCam Appoints Seasoned Hi-Tech Executive Yovav Sameah as Chief Executive Officer

    OMER, Israel, March 08, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, announced today that ScoutCam Inc (OTCQB:SCTC), Medigus’ subsidiary and a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, appointed Mr. Yovav Sameah as ScoutCam’s new Chief Executive Officer. Mr. Sameah will replace Dr. Yaron Silberman, who will step down to pursue new opportunities. Mr. Sameah is a senior level executive with extensive hands-on experience in management, business leadership and strategy. He most recently served as CEO of Frontline PCB So

    $MDGS
    Medical/Dental Instruments
    Health Care

$MDGS
Financials

Live finance-specific insights

See more
  • Medigus Acquires 19.9% of Innovative AI and Natural Language Processing Communication Based Software Company

    Metagramm Software Ltd. has developed an advanced grammar engine, which serves as the core of its online writing solution and a fully integrated writing solution for Windows desktop Tel Aviv, Israel, April 13, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today it has acquired 19.9% of Metagramm Software Ltd. ("Metagramm"), an innovative AI, machine learning (ML) communication and grammar assistant software. In return, Medigus paid Metagramm $250,000 in Medigus' common shares. Metagramm is one of the first comp

    $MDGS
    Medical/Dental Instruments
    Health Care
  • Medigus Announces Record 2022 First Half Financial Results

    TEL AVIV, Israel, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) ("Medigus"), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today reported financial results for the six months ended June 30, 2022. Key Highlights Generated record revenues of $34.95 million in the first half of 2022, compared to $2.39 million revenues in the first half of 2021Gross profit reached a record $6.19 million in the first half of 2022, up from a gross profit of $0.6 million in the first half of 2021Cash and cash equivalents as of June 30, 2022 were $22.1 millionShareholders' equity improved to $53.19 million

    $MDGS
    Medical/Dental Instruments
    Health Care
  • Medigus Board Files a Motion to Approve an Up to $1.6 Million Dividend Distribution

    Tel Aviv, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that the Company filed a motion with the Tel Aviv District Court Economic Department for approval of a dividend distribution  up to of $1.6 million. The Company's motion, if approved as requested, would permit the Company to distribute a dividend to the holders of the Company's American Depositary Shares in proportion to their respective holdings. A separate announcement would be made if the Company's board of directors were to declare such a dividend.

    $MDGS
    Medical/Dental Instruments
    Health Care

$MDGS
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more